Jason Miele
Analyst · MST Marquee. Please go ahead
Thanks, Sean. Let's turn to Page 8. Our Asia Pacific team has also delivered a remarkable step-change in performance over the past three years and a significant change in the scale of the business, a 58% increase in adjusted EBIT and 16% volume growth is excellent leverage across this three-year period. More importantly, the business continues to grow and scale. And is now over A$200 million of the EBIT, it represents a substantial business that can significantly impact the group results. Similar to North America, the adjusted EBIT margin expansion is significant at 570 basis points and the team has delivered at the top end of the new long-term target range two years in a row. Turning to Page 9, let's discuss Europe. In February of 2019, shortly after the acquisition of Fermacell, we laid out long-term targets for our new European business, as well as short-term guidance to measure our success against. Our long-term targets remain unchanged in our 10th year of operations in Europe. Post-acquisition, we expect to be a €1 billion net sales business with an EBIT margin over 20%. And over these past three years, the European team has delivered against the short term targets we laid out in February of 2019. The first target we set at that time was a net sales CAGR of 8% to 12% during the three-year period ending with fiscal year 2022. We delivered a 10% net sales CAGR right in the middle of the range. The second metric we committed to was exiting fiscal year 2022 with a 14% EBIT margin. You'll see, on this chart, we delivered 12.9% EBIT margin in fiscal year 2022, which is below the original target of 2014. However, if you remove the impacts of hyperinflation in fiscal year 2022, the team would have delivered in full year, EBIT margin 220 basis points higher than the 12.9%, which is well above the initial target of 14% we set out in February of 2019. The European team has integrated tremendously well into James Hardie, and they have a clear strategy to continue to drive growth and margin expansion into the future. Let's turn to Page 10, which is the last slide in this section. As you have heard, Harold Sean and I discuss, we believe as we enter fiscal year 2023, we are a global company that is enabled for continued growth. Through the acquisition of Europe in April, 2018 and the execution of our strategy to transform our business these past three fiscal years, we have step-changed our financial profile and believe we have the right go-forward strategy to continue to deliver growth above market with strong returns. I want to spend a few minutes discussing the middle section of this slide. As you can see here, the financial strength of the global organization has changed significantly during this three-year period. It is a key factor in enabling our future strategic plans, which are articulated on the right of the slide. First, we have delivered a step-change in our P&L performance and scale. Global net sales has increased to US$3.6 billion in fiscal year 2022. Adjusted net income more than doubled in the past three years to US$621 million. We also raised our long-term EBIT margin ranges in all three regions in May of 2021. And in fiscal year 2022, we delivered at the top end of those ranges. Second, we have also delivered a step-change in our operating cash flows growing from US$304 million in fiscal year 2019, to US$757 million in fiscal year 2022. And over the past two-year period combined, our operating cash flow has exceeded US$1.5 billion. Third we have significantly improved our balance sheet over this period. Our leverage has decreased from 2.4 times on March 31, 2019 to 0.8 times as of March 31, 2022. And we decreased our net debt from US$1.3 billion at March 31, 2019 to US$752 million as of March 31, 2022. And fourth, the AICF also now has a much improved balance sheet. As of March 31, 2019 the AICF had cash in investments of A$81 million. And as of March 31, 2022, they have A$350 million in cash and investments. And as we discussed last quarter, the top up calculation will apply in July of 2022 and we currently estimate that payment will be 19% of operating cash flow, a significant change from the historic 35% rate. Our global team has created an incredible platform upon which to enable our future growth. And we believe we have the right strategy to continue to deliver growth above market and strong returns as we move into fiscal year 2023 and beyond. We have spent a decent amount of time discussing our three-year transformation. Let's now shift to Page 12 to discuss our fiscal year 2022 results. In the fourth quarter, the global team continued to deliver growth above market and strong returns, with all three regions delivering double digit net sales growth. The global teams’ execution resulted in global net sales increase 20% to US$968.2 million for the quarter. For the full fiscal year 2022 net sales increased 24% to over US$3.6 billion. Global adjusted EBIT increased 30% to US$225.3 million for the quarter and US$815.6 million for the full year, both representing a 30% increase over the prior corresponding period. Global adjusted net income increased 42% to US$177.5 million for the quarter and was up 36% to US$620.7 million for the 12 months. All of our businesses performed extremely well in fiscal year 2022. And this operational performance would have delivered an adjusted net income result towards the top of our adjusted net income guidance range of US$620 million and US$630 million. However, higher general corporate costs in the fourth quarter resulted in adjusted net income of US$620.7 million. Full year operating cash flow was strong at US$757.2 million. And adjusting for the one-off U.S. CARES Act tax refund in fiscal year 2021, operating cash flow was up 5% versus the prior year. Let’s move to Page 13 to discuss the North America results. In the fourth quarter, the North America team delivered net sales growth of 25% to US$694 million. The team delivered strong volume growth of 13% and exceptional price mix growth of 12%. The price mix growth was delivered through continued execution and driving high value product penetration and close partnership with our customers. In addition with continued execution of our foundational initiatives, we were able to convert the top line result into a strong bottom line outcome with adjusted EBIT increasing 35% to US$206.1 million at a margin of 29.7%. For the full year net sales increased 25% to just over US$2.5 billion on volume growth of 15% and price mix growth of 10%. A key contributor to price mix growth as well as margin performance was delivery of a 27% increase in ColorPlus volumes in fiscal year 2022 versus fiscal year 2021. Adjusted EITT was US$741.2 million for the 12 months with an impressive adjusted EBIT margin of 29.1%. The team delivered a 20 basis point improvement in adjusted EBIT margins for the full year. This was achieved through continued lean manufacturing improvements combined with driving a high value product mix, helping to offset cost inflation and significant investment in future growth through marketing, innovation and talent capability. Let’s move now to Page 14 to discuss Asia Pacific. The Asia Pacific team delivered fourth quarter net sales growth of 23% to A$200.5 million. The APAC business continues its step change execution in driving high value product penetration with price mix growth of 11% in the quarter with volume growth of 12%. In the fourth quarter, execution on LEAN manufacturing and a focus on high value product mix, help to offset the inflationary environment leading to strong adjusted EBIT growth of 21% at an adjusted EBIT margin of 26.3%. It was a strong fiscal year for the Asia-Pacific business with full year net sales increasing 22% to A$777.7 million and adjusted EBIT improved 23% to A$217.4 million at an outstanding margin of 28%. Turning now to Page 15, let's discuss the European results. In Europe, during the fourth quarter, net sales increased 10% to €115 million and adjusted EBIT increased 3% to €16.1 million. Quarterly net sales growth was delivered through the team's continued execution of the high value product penetration strategy as well as a January 1, 2022 price increase, which led to price mix growth of 14%. Fourth quarter volume decreased 4% as we strategically shifted away from low margin partnerships. There was some minor reduction in demand in the period. And we were comping a prior year fourth quarter, which included some of our initial new innovation VL Plank stocking positions. Encouragingly, fourth quarter adjusted EBIT margin returned to expected levels at 14% as we had indicated they would when we spoke three months ago. Fiber Cement net sales increased 18% in the quarter while Fiber Gypsum increased 9%. Full year net sales increased 20% to €420.5 million with an impressive 39% increase in Fiber Cement net sales and a 17% increase in Fiber Gypsum net sales. Adjusted EBIT improved 51% to €54.2 million at a margin of 12.9%. We are particularly pleased that European EBIT margins have improved in line with our expectations set three years ago, excluding the impacts of hyperinflation the full year EBIT margin would have been 220 basis point higher in fiscal year 2022, exceeding our original target of 14% set back in February of 2019. As you know, natural gas is a key input cost for the manufacturing of Fiber Gypsum and with prices remaining high; the European team has taken another price increase effective on April 1, 2022. Now that we are able to travel more freely again, had the pleasure to be in our European business over the past few weeks, along with Harold and Ryan Kilcullen. I want to thank the team there for the excellent job they've done in integrating into James Hardie, hitting all of the targets we set together over these first four years and positioning the business to deliver on our initial 10-year plan of becoming a €1 billion business with over 20% EBIT margins. We are extremely encouraged by the success to-date and the strategy the team has in place to deliver on our long-term targets. I will now turn it over to Sean Gadd.